Geke Hospers

13PUBLICATIONS
122CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 01, 2026
Five-year survival with neoadjuvant therapy in melanoma: updated pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC).

|Jun 25, 2026
Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling.

|Jan 28, 2026
Neoadjuvant ipilimumab plus nivolumab in melanoma: 5-year survival and biomarker analysis from the phase 2 PRADO-trial.

Lotte L Hoeijmakers, Petros Dimitriadis, Steven C M A Wijnen

|Apr 15, 2025
Adjuvant BRAF/MEK versus anti-PD-1 in BRAF-mutant melanoma: a propensity score matched survival analysis.

M Bloem, M M de Meza, A J M van den Eertwegh

|Feb 16, 2024
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma.

Johannes R Björk, Laura A Bolte, Andrew Maltez Thomas

|Nov 13, 2023
Association between pretreatment emotional distress and neoadjuvant immune checkpoint blockade response in melanoma.

Itske Fraterman, Irene L M Reijers, Petros Dimitriadis

Pageof 3

Frequent Collaborators

6 joint publications

Christian U Blank

5 joint publications

Karijn P M Suijkerbuijk

4 joint publications

Georgina V Long

4 joint publications

Ellen W Kapiteijn